This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Vincent P. Barranco, MD

Arch Dermatol. 1974;110(4):563-566.

Abstract
The possible inhibition of lysosomal enzymes by dapsone (diaminodiphenylsulfone) was studied. Experimentally induced hypervitaminosis A in rabbits results in loss of chondroitin sulfate from cartilage matrix through the release of lysosomal enzymes.

In this study, thinning and decreased toluidine blue and Alcian blue staining of tracheal and articular cartilage produced by the administration of 500,000 international units of vitamin A daily were inhibited by the administration of dapsone. These findings strongly suggest that dapsone inhibits lysosomal enzyme activity. Inhibition of lysosomal enzyme activity may play a role in the therapeutic effects of dapsone on certain diseases such as dermatitis herpetiformis.

Author Affiliations
From the Department of Dermatology, University of Oklahoma Health Sciences Center, and the Tulsa Dermatology Clinic, Tulsa, Okla.

Footnotes
Accepted for publication March 14, 1974.

Reprint requests to Tulsa Dermatology Clinic, Box 4088, Tulsa, OK 74152 (Dr. Barranco).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris
Heaphy et al.
Arch Dermatol 2005;141:699-702.
ABSTRACT | FULL TEXT  

Dapsone as Initial Treatment in Superficial Pemphigus: Report of Nine Cases
Basset et al.
Arch Dermatol 1987;123:783-785.
ABSTRACT  

Acute Febrile Neutrophilic Dermatosis (Sweet's Syndrome) Response to Dapsone
Aram
Arch Dermatol 1984;120:245-247.
ABSTRACT  

Commentary: Sulfoxone (Diasone) in the Treatment of Dermatitis Herpetiformis
Katz
Arch Dermatol 1982;118:809-812.
ABSTRACT  

Facial Granuloma Responsive to Dapsone Therapy
Guill and Aton
Arch Dermatol 1982;118:332-335.
ABSTRACT  

Dapsone-Responsive, Noninfectious Verrucous Pyoderma: Its Occurrence Following Cisplatin Therapy
Person and Schwartz
Arch Dermatol 1982;118:336-338.
ABSTRACT  

Dermatitis Herpetiformis: The Skin and the Gut
KATZ et al.
ANN INTERN MED 1980;93:857-874.
ABSTRACT  

Pemphigus Vegetans: Its Relationship to Eosinophilic Spongiosis and Favorable Response to Dapsone
Pearson et al.
Arch Dermatol 1980;116:65-68.
ABSTRACT  

Acropustulosis of Infancy
Kahn and Rywlin
Arch Dermatol 1979;115:831-833.
ABSTRACT  

Relapsing Polychondritis: Unusual Neurological Findings and Therapeutic Efficacy of Dapsone
Ridgway et al.
Arch Dermatol 1979;115:43-45.
ABSTRACT  

Relapsing Polychondritis With Positive Direct Immunofluorescence
Bergfeld
Arch Dermatol 1978;114:127-127.
ABSTRACT  

Erythema Elevatum Diutinum: Response to Dapsone
Fort and Rodman
Arch Dermatol 1977;113:819-822.
ABSTRACT  

Bullous Pemphigoid Responding to Sulfapyridine and the Sulfones
Person and Rogers
Arch Dermatol 1977;113:610-615.
ABSTRACT  

Relapsing Polychondritis Treated With Dapsone
Martin et al.
Arch Dermatol 1976;112:1272-1274.
ABSTRACT  

Treatment of Relapsing Polychondritis With Dapsone
Barranco et al.
Arch Dermatol 1976;112:1286-1288.
ABSTRACT